Clinical Trial Update: Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating safety and quality of life in elderly patients with advanced/metastatic cancer undergoing immunotherapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Advanced or Metastatic Melanoma, Advanced or Metastatic NSCLC | Phase 4 | Status: TERMINATED